Free Access
Issue
Med Sci (Paris)
Volume 20, Number 8-9, Août-Septembre 2004
Page(s) 799 - 803
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004208-9799
Published online 15 August 2004
  1. Vogt W. Pharmacologically active acidic phospholipds and glycolipids. Biochem Pharmacol 1963; 12 : 415–20. [Google Scholar]
  2. Tokumura A, Fukuzawa K, Akamatsu Y, et al. Identification of vasopressor phospholipid in crude soybean lecithin. Lipids 1978; 13 : 468–72. [Google Scholar]
  3. Schumacher KA, Classen HG, Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives : Identity with substances in aged serum (DAS). Thromb Haemost 1979; 42 : 631–40. [Google Scholar]
  4. Mauco G, Chap H, Simon MF, Douste-Blazy L. Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie 1978; 60 : 653–61. [Google Scholar]
  5. Van Corven EJ, Groenink A, Jalink K, et al. Lysophosphatidate-induced cell proliferation : Identification and dissection of signaling pathways mediated by G proteins. Cell 1989; 59 : 45–54. [Google Scholar]
  6. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996; 135 : 1071–83. [Google Scholar]
  7. Aoki J, Taira A, Takanezawa Y, et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002; 277 : 48737–44. [Google Scholar]
  8. Westermann A, Havik E, Postma F, et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 1998; 9 : 437–42. [Google Scholar]
  9. Tokumura A, Miyake M, Nishioka Y, et al. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol Reprod 1999; 61 : 195–9. [Google Scholar]
  10. Jaspard B, Collet X, Barbaras R, et al. Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid : Evidence for the presence of a lipid core. Biochemistry 1996; 35 : 1352–7. [Google Scholar]
  11. Valet P, Pages C, Jeanneton O, et al. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest 1998; 101 : 1431–8. [Google Scholar]
  12. Liliom K, Guan Z, Tseng JL, et al. Growth factor-like phospholipids generated after corneal injury. Am J Physiol 1998; 274 : C1065–74. [Google Scholar]
  13. Sugiura T, Nakane S, Kishimoto S, et al. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J Lipid Res 2002; 43 : 2049–55. [Google Scholar]
  14. Capper EA, Marshall LA. Mammalian phospholipases A(2) : Mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 2001; 40 : 167–97. [Google Scholar]
  15. Fourcade O, Simon MF, Viodé C, et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995; 80 : 919–27. [Google Scholar]
  16. Tokumura A, Miyabe M, Yoshimoto O, et al. Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma. Lipids 1998; 33 : 1009–15. [Google Scholar]
  17. Gesta S, Simon M, Rey A, et al. Secretion of a lysophospholipase D activity by adipocytes : Involvement in lysophosphatidic acid synthesis. J Lipid Res 2002; 43 : 904–10. [Google Scholar]
  18. Tokumura A, Majima E, Kariya Y, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002; 277 : 39436–42. [Google Scholar]
  19. Ferry G, Tellier E, Try A, et al. Autotaxin is released from adipocytes, catalyses lysophosphatidic acid synthesis, and activates preadipocyte proliferation : Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 2003; 278 : 18162–9. [Google Scholar]
  20. Bollen M, Gijsbers R, Ceulemans H, et al. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000; 35 : 393–432. [Google Scholar]
  21. Brindley DN, English D, Pilquil C, et al. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim Biophys Acta 2002; 1582 : 33–44. [Google Scholar]
  22. Simon MF, Rey A, Castan-Laurel I, et al. Expression of ecto-lipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes : Involvement in the control of lysophosphatidic acid production. J Biol Chem 2002; 277 : 23131–6. [Google Scholar]
  23. Chun J, Goetzl EJ, Hla T, et al. International union of pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 2002; 54 : 265–9. [Google Scholar]
  24. Ishii I, Contos JJ, Fukushima N, Chun J. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 2000; 58 : 895–902. [Google Scholar]
  25. Wu J, Cunnick JM. Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors. Biochim Biophys Acta 2002; 1582 : 100–6. [Google Scholar]
  26. Contos JJ, Fukushima N, Weiner JA, et al. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000; 97 : 13384–9. [Google Scholar]
  27. Contos JJ, Ishii I, Fukushima N, et al. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice : Signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 2002; 22 : 6921–9. [Google Scholar]
  28. Tigyi G, Hong L, Yakubu M, et al. Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am J Physiol 1995; 268 : H2048–55. [Google Scholar]
  29. Karliner JS. Lysophospholipids and the cardiovascular system. Biochim Biophys Acta 2002; 1582 : 216–21. [Google Scholar]
  30. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2000; 1582 : 204–15. [Google Scholar]
  31. Sturm A, Sudermann T, Schulte KM, et al. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 1999; 117 : 368–77. [Google Scholar]
  32. Balazs L, Okolicany J, Ferrebee M, et al. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol 2001; 280 : R466–72. [Google Scholar]
  33. Merchant TE, Kasimos JN, de Graaf PW, et al. Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis 1991; 6 : 121–6. [Google Scholar]
  34. Baker DL, Morrison P, Miller B, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. Jama 2002; 287 : 3081–2. [Google Scholar]
  35. Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280 : 719–23. [Google Scholar]
  36. Fang X, Schummer M, Mao M, et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta. 2002; 1582 : 257–64. [Google Scholar]
  37. Tokumura A, Kanaya Y, Miyake M, et al. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol Reprod 2002; 67 : 1386–92. [Google Scholar]
  38. Budnik LT, Mukhopadhyay AK. Lysophosphatidic acid and its role in reproduction. Biol Reprod 2002; 66 : 859–65. [Google Scholar]
  39. Pagès C, Daviaud D, An S, et al. Endothelial differentiation gene-2 receptor is involved in lysophosphatidic acid- dependent control of 3T3F442A preadipocyte proliferation and spreading. J Biol Chem 2001; 276 : 11599–605. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.